AngioDynamics Inc
NASDAQ:ANGO
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
James Latham PLC
LSE:LTHM
|
UK |
|
Accentis NV
XBRU:ACCB
|
BE |
|
Sony Group Corp
NYSE:SONY
|
JP |
|
C
|
Canvest Environmental Protection Group Company Ltd
HKEX:1381
|
HK |
|
Ming Yuan Cloud Group Holdings Ltd
HKEX:909
|
CN |
AngioDynamics Inc
Other Equity
AngioDynamics Inc
Other Equity Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Other Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
AngioDynamics Inc
NASDAQ:ANGO
|
Other Equity
$2.7m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
7%
|
CAGR 10-Years
N/A
|
|
|
Boston Scientific Corp
NYSE:BSX
|
Other Equity
-$609m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Edwards Lifesciences Corp
NYSE:EW
|
Other Equity
-$237.5m
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-3%
|
|
|
Stryker Corp
NYSE:SYK
|
Other Equity
-$687m
|
CAGR 3-Years
-46%
|
CAGR 5-Years
10%
|
CAGR 10-Years
-1%
|
|
|
Abbott Laboratories
NYSE:ABT
|
Other Equity
-$6B
|
CAGR 3-Years
9%
|
CAGR 5-Years
8%
|
CAGR 10-Years
1%
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Other Equity
$13.8m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-7%
|
CAGR 10-Years
N/A
|
|
AngioDynamics Inc
Glance View
AngioDynamics, Inc. is a medical device company, which engages in the development, manufacture, and sale of medical devices for vascular access, surgery, peripheral vascular disease, and oncology. The company is headquartered in Latham, New York and currently employs 800 full-time employees. The company went IPO on 2004-05-27. Its devices are used in minimally invasive, image-guided procedures. Its product offerings include Endovascular Therapies, Oncology/Surgery (OS) and Vascular Access (VA). Its Endovascular Therapies product offerings support the medical areas of Thrombus Management, Atherectomy, Peripheral Products (Core) and Venous Insufficiency. Its OS product offerings includes a range of ablation technologies, including thermal tissue ablation systems, surgical resection and the Irreversible Electroporation (IRE) technology, the NanoKnife System. Its portfolio of VA products includes peripherally inserted central catheters (PICCs), midline catheters, implantable ports, dialysis catheters and related accessories and supplies.
See Also
What is AngioDynamics Inc's Other Equity?
Other Equity
2.7m
USD
Based on the financial report for Feb 28, 2026, AngioDynamics Inc's Other Equity amounts to 2.7m USD.
What is AngioDynamics Inc's Other Equity growth rate?
Other Equity CAGR 5Y
7%
